Jordina Rovira

Villarroel St. 170
Barcelona, CT 08036, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study.

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study.

Journal: Blood advances

Published: November 25, 2024

Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.

Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.

Journal: British journal of haematology

Published: July 11, 2022

Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.

Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.

Journal: British journal of haematology

Published: June 14, 2021

Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study.

Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 02, 2020

Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era.

Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era.

Journal: European journal of haematology

Published: October 25, 2019

Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era.

Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era.

Journal: British journal of haematology

Published: August 17, 2018

High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma.

High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma.

Journal: Leukemia research

Published: March 20, 2017

T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcome.

T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcome.

Journal: Leukemia & lymphoma

Published: October 01, 2016

HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma.

HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: September 15, 2016

Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Journal: Annals of hematology

Published: September 01, 2016

Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β2 -microglobulin yields a more accurate GELTAMO-IPI.

Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β2 -microglobulin yields a more accurate GELTAMO-IPI.

Journal: British journal of haematology

Published: July 20, 2016

MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome.

MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 12, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026